Skip to content

NIRS to Evaluate Haemodynamic Reserve in Paediatric Moyamoya

NIRS to Evaluate Haemodynamic Reserve in Paediatric Moyamoya

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05160454
Acronym
NIRS moyamoya
Enrollment
20
Registered
2021-12-16
Start date
2018-02-14
Completion date
2022-06-30
Last updated
2021-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya

Brief summary

Near infrared spectroscpy is a validated method of evaluating cerebral blood flow. The aim in this pilot study to explore its use in children with moyamoya disease.

Detailed description

Moyamoya disease is a cerebrovascular condition in which there is chronic brain hypoperfusion. As surgery can possibly augment brain blood flow, a method for evalutaing cerebrovascualr reserve would be helpful in selecting patients for intervention. Near infrared spectroscopy (NIRS) is a validated non-invasive method of evaluating cerebral blood flow. We aim to investigate the feasibility and tolerability of using NIRS haemodynamic reserve in children with moyamoya and controls by evaluating cerebral blood flow in the baseline state and after breath-holding. Feasibility will be assessed by how many successful studies are carried out. Tolerability will be assessed by asking children some simple questions about their experience.

Interventions

DEVICEnear infrared spectroscopy

evaluate cerebral blood flow with and without breatholding

Sponsors

Great Ormond Street Hospital for Children NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

patients and controls

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

Patients with moyamoya and unaffected healthy controls -

Exclusion criteria

age \<6 \-

Design outcomes

Primary

MeasureTime frameDescription
Number of NIRS studies that can be completed in moyamoya patients2yearshow many studies can be completed

Secondary

MeasureTime frameDescription
Patient questionnaire to evaluate children's experience of NIRS in moyamoya2yearsask children re their experience

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026